+

WO2002060466A3 - Polynucleotides et polypeptides gssp3 et utilisations de ces derniers - Google Patents

Polynucleotides et polypeptides gssp3 et utilisations de ces derniers Download PDF

Info

Publication number
WO2002060466A3
WO2002060466A3 PCT/IB2002/001333 IB0201333W WO02060466A3 WO 2002060466 A3 WO2002060466 A3 WO 2002060466A3 IB 0201333 W IB0201333 W IB 0201333W WO 02060466 A3 WO02060466 A3 WO 02060466A3
Authority
WO
WIPO (PCT)
Prior art keywords
metabolic
disorders
gssp3
polypeptides
polynucleotides
Prior art date
Application number
PCT/IB2002/001333
Other languages
English (en)
Other versions
WO2002060466A2 (fr
Inventor
Luisa Salter-Cid
Dana Ebbets-Reed
Barbara A Bour
John Chicca
Frances Yen-Potin
Bernard Bihain
Original Assignee
Genset Sa
Luisa Salter-Cid
Dana Ebbets-Reed
Barbara A Bour
John Chicca
Frances Yen-Potin
Bernard Bihain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genset Sa, Luisa Salter-Cid, Dana Ebbets-Reed, Barbara A Bour, John Chicca, Frances Yen-Potin, Bernard Bihain filed Critical Genset Sa
Priority to EP02720403A priority Critical patent/EP1355657A2/fr
Priority to US10/467,046 priority patent/US20040235709A1/en
Priority to AU2002251433A priority patent/AU2002251433A1/en
Publication of WO2002060466A2 publication Critical patent/WO2002060466A2/fr
Publication of WO2002060466A3 publication Critical patent/WO2002060466A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention a trait au domaine de la recherche métabolique. Les troubles du métabolisme, tels que l'obésité, représentent un problème de santé publique sérieux et répandu. L'invention concerne l'identification de polypeptides GSSP3 que l'on croit bénéfiques au traitement des troubles du métabolisme. Les composés de l'invention sont efficaces dans la réduction de la masse corporelle et dans le traitement de maladies et troubles liés au métabolisme, parmi lesquels l'hyperlipidémie, l'athérosclérose, le diabète et l'hypertension.
PCT/IB2002/001333 2001-02-02 2002-02-01 Polynucleotides et polypeptides gssp3 et utilisations de ces derniers WO2002060466A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP02720403A EP1355657A2 (fr) 2001-02-02 2002-02-01 Polynucleotides et polypeptides gssp3 et utilisations de ces derniers
US10/467,046 US20040235709A1 (en) 2001-02-02 2002-02-01 Gssp3 polynucleotides and polypeptides and uses thereof
AU2002251433A AU2002251433A1 (en) 2001-02-02 2002-02-01 Gssp3 polynucleotides and polypeptides and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26615601P 2001-02-02 2001-02-02
US60/266,156 2001-02-02

Publications (2)

Publication Number Publication Date
WO2002060466A2 WO2002060466A2 (fr) 2002-08-08
WO2002060466A3 true WO2002060466A3 (fr) 2003-03-13

Family

ID=23013406

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2002/001333 WO2002060466A2 (fr) 2001-02-02 2002-02-01 Polynucleotides et polypeptides gssp3 et utilisations de ces derniers

Country Status (4)

Country Link
US (1) US20040235709A1 (fr)
EP (1) EP1355657A2 (fr)
AU (1) AU2002251433A1 (fr)
WO (1) WO2002060466A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60141827D1 (de) * 2000-05-31 2010-05-27 Serono Genetics Inst Sa Verwendung des globulären kopfes von acrp30 zur verstärkung der zunahme von muskelmasse und -differenzierung

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000061623A1 (fr) * 1999-04-09 2000-10-19 Human Genome Sciences, Inc. Soixante-deux protéines humaines sécrétées
EP1104808A1 (fr) * 1999-08-05 2001-06-06 Genset ESTs et leurs protéines codées humaines
WO2001042451A2 (fr) * 1999-12-08 2001-06-14 Genset ADNc HUMAINS PLEINE LONGUEUR CODANT POUR DES PROTEINES POTENTIELLEMENT SECRETEES

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019369A (en) * 1984-10-22 1991-05-28 Vestar, Inc. Method of targeting tumors in humans
US4914025A (en) * 1985-12-05 1990-04-03 Colin Manoil Export of intra-cellular substances
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
US5908635A (en) * 1994-08-05 1999-06-01 The United States Of America As Represented By The Department Of Health And Human Services Method for the liposomal delivery of nucleic acids
US5872141A (en) * 1997-02-18 1999-02-16 Umbreit; Jay N. Method of inhibiting cholesterol transport
US6034062A (en) * 1997-03-13 2000-03-07 Genetics Institute, Inc. Bone morphogenetic protein (BMP)-9 compositions and their uses
US6242179B1 (en) * 1997-12-17 2001-06-05 Incyte Pharmaceuticals, Inc. Human phosphatases

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000061623A1 (fr) * 1999-04-09 2000-10-19 Human Genome Sciences, Inc. Soixante-deux protéines humaines sécrétées
EP1104808A1 (fr) * 1999-08-05 2001-06-06 Genset ESTs et leurs protéines codées humaines
WO2001042451A2 (fr) * 1999-12-08 2001-06-14 Genset ADNc HUMAINS PLEINE LONGUEUR CODANT POUR DES PROTEINES POTENTIELLEMENT SECRETEES

Also Published As

Publication number Publication date
EP1355657A2 (fr) 2003-10-29
US20040235709A1 (en) 2004-11-25
AU2002251433A1 (en) 2002-08-12
WO2002060466A2 (fr) 2002-08-08

Similar Documents

Publication Publication Date Title
IL150554A0 (en) Obg3 globular head and uses therof for decreasing body mass
MXPA04005790A (es) Compuestos y usos de los mismos para reducir la actividad de la lipasa sensible a la hormona.
WO2003057144A3 (fr) Changement d'inhibiteurs de la dipeptidyl peptidase iv
WO2001013906A3 (fr) Composition comprenant du modafinil pour traiter les troubles de l'alimentation et stimuler l'appetit
MXPA04003796A (es) Tioacetamidas sustituidas.
WO2003099266A3 (fr) Acetamides et benzamides utilises dans le traitement d'une dysfonction sexuelle
WO2003039453A3 (fr) Compositions de peroxyde de dibenzoyle pour le traitement de troubles dermatologiques, et procedes d'utilisation correspondants
WO2003050281A3 (fr) Polynucleotides et polypetides gzip et leurs utilisations
WO2003033534A3 (fr) Polynucleotides et polypeptides ngzipa, ngzipd, pgzipa et pgzipd et utilisations de ceux-ci
WO2002066505A3 (fr) Polynucleotides et polypeptides gmg-3, gmg-4, et gmg-6 et utilisations associees
WO2002060466A3 (fr) Polynucleotides et polypeptides gssp3 et utilisations de ces derniers
WO2003084503A3 (fr) Procede de traitement de l'hypersecretion de mucus
EP1546377A4 (fr) Methodes et compositions de traitement de la douleur et des troubles douloureux a l'aide des molecules 9949, 14230, 760, 62553, 41897, 47174, 33408, 10002,16209, 314, 636, 27410, 33260, 619,15985, 69112, 2158, 224, 615, 44373, 95431, 22245, 2387, 16658, 55054, 9569 ou 13424
WO2003051911A3 (fr) Polypeptides et polynucleotides gmg-5 et utilisations de ceux-ci
WO2002055694A3 (fr) Polynucleotides et polypeptides de genes metaboliques et leurs utilisations
WO2003082915A3 (fr) Polynucleotides polypeptides xcrf et leurs utilisations
WO2004043365A3 (fr) Methode de traitement de l'ejaculation precoce chez les humains
AU2002360531A1 (en) Methods and compositions to treat cardiovascular disease using 1419, 58765 and 2201
WO2003095485A3 (fr) Polynucleotides et polypeptides krib et utilisations de ceux-ci dans le traitement de troubles metaboliques
AU2003255843A1 (en) 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain
WO2002069689A3 (fr) Polynucleotides et polypeptides gssp4 et utilisations de ces derniers
AU2002348299A8 (en) Methods and compositions for the treatment of pain and other hormone-allergy-related symptoms using dilute hormone solutions
WO2003013578A8 (fr) Traitement des troubles metabolique au moyen d'agonistes et d'antagonistes d'omoxine
AU2002357691A1 (en) Methods and compositions to treat pain and painful disorders using 577, 20739 or 57145
AU2002360343A1 (en) Methods and compositions to treat cardiovascular disease using 139, 258, 1261, 1486, 2398, 2414, 7660, 8587, 10183, 10550, 12680, 17921, 32248, 60489 or 93804

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2002720403

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002720403

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 10467046

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWR Wipo information: refused in national office

Ref document number: 2002720403

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2002720403

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载